Stock Movers Novo Rebounds, Natwest Buys, InPost Deal
Feb 9, 2026
Chloe Malay, Bloomberg reporter who covers European markets and corporate news, breaks down market-moving deals. She explains Novo Nordisk’s stock rebound after regulators sidelined a copycat drug. She covers NatWest’s big purchase to boost wealth management. She walks through the €7.8bn InPost takeover led by Advent and FedEx.
AI Snips
Chapters
Transcript
Episode notes
Regulator Clampdown Helped Novo Rebound
- The FDA pressured copycat sellers, prompting Hims & Hers to stop selling knockoff weight-loss pills.
- Chloe Malay says this removal eases pressure on Novo Nordisk's new obesity drug outlook.
Novo's Super Bowl Advertising Play
- Caroline Hepker mentions Novo Nordisk ran a Super Bowl advert as part of its U.S. push.
- She frames the ad slot as a high-profile and expensive move to reach American consumers.
NatWest Targets Wealthy Clients
- NatWest will buy Evelyn Partners to access wealthier UK clients and grow fee-based income.
- Chloe Malay explains the move is meant to diversify away from mortgages and loans as rates fall.